Report Detail

Global Drug Discovery Informatics Market Size study, By Function (Sequencing & Target Data Analysis, Docking, Molecular Modelling, Libraries & Database Preparation and other functions), By Solutions (Software and Services), By End-users (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROS) and other end-users) and Regional Forecasts 2019-2026

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Key Trends
  • 1.3. Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Million)
    • 1.3.1. Drug Discovery Informatics Market, by Function, 2016-2026 (USD Million)
    • 1.3.2. Drug Discovery Informatics Market, by Solution , 2016-2026 (USD Million)
    • 1.3.3. Drug Discovery Informatics Market, by End-user 2016-2026 (USD Million)
    • 1.3.4. Drug Discovery Informatics Market, by Region, 2016-2026 (USD Million)
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Drug Discovery Informatics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Drug Discovery Informatics Market Dynamics

  • 3.1. See Saw Analysis
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Drug Discovery Informatics Market Industry Analysis

  • 4.1. Porter’s 5 Force Model
    • 4.1.1. Bargaining Power of Buyers
    • 4.1.2. Bargaining Power of Suppliers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter’s 5 Force Model
  • 4.2. PEST Analysis
    • 4.2.1. Political Scenario
    • 4.2.2. Economic Scenario
    • 4.2.3. Social Scenario
    • 4.2.4. Technological Scenario
  • 4.3. Key Buying Criteria (On Demand)
  • 4.4. Regulatory Framework (On Demand)
  • 4.5. Investment Vs Adoption Scenario (On Demand)
  • 4.6. Analyst Recommendation & Conclusion

Chapter 5. Global Drug Discovery Informatics Market, by Function

  • 5.1. Market Snapshot
  • 5.2. Market Performance - Potential Model
  • 5.3. Drug Discovery Informatics Market, Sub Segment Analysis
    • 5.3.1. Sequencing & Target Data Analysis
      • 5.3.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 5.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
    • 5.3.2. Docking
      • 5.3.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 5.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
    • 5.3.3. Molecular Modelling
      • 5.3.3.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 5.3.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
    • 5.3.4. Libraries & Database Preparation
      • 5.3.4.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 5.3.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
    • 5.3.5. Other Functions
      • 5.3.5.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 5.3.5.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)

    Chapter 6. Global Drug Discovery Informatics Market, by Solution

    • 6.1. Market Snapshot
    • 6.2. Market Performance - Potential Model
    • 6.3. Drug Discovery Informatics Market, Sub Segment Analysis
      • 6.3.1. Software
        • 6.3.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
        • 6.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 6.3.2. Services
        • 6.3.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
        • 6.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)

      Chapter 7. Global Drug Discovery Informatics Market, by End User

      • 7.1. Market Snapshot
      • 7.2. Market Performance - Potential Model
      • 7.3. Drug Discovery Informatics Market, Sub Segment Analysis
        • 7.3.1. Pharmaceutical and Biotechnology Companies
          • 7.3.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
          • 7.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
        • 7.3.2. Contract Research Organizations (CROS)
          • 7.3.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
          • 7.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
        • 7.3.3. Others End Users
          • 7.3.3.1. Market estimates & forecasts, 2016-2026 (USD Million)
          • 7.3.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)

        Chapter 8. Global Drug Discovery Informatics Market, by Regional Analysis

        • 8.1. Drug Discovery Informatics Market, Regional Market Snapshot (2016-2026)
        • 8.2. North America Drug Discovery Informatics Market Snapshot
          • 8.2.1. U.S.
            • 8.2.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
            • 8.2.1.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 8.2.1.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 8.2.1.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
          • 8.2.2. Canada
            • 8.2.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
            • 8.2.2.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 8.2.2.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 8.2.2.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
        • 8.3. Europe Drug Discovery Informatics Market Snapshot
          • 8.3.1. U.K.
            • 8.3.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
            • 8.3.1.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 8.3.1.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 8.3.1.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
          • 8.3.2. Germany
            • 8.3.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
            • 8.3.2.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 8.3.2.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 8.3.2.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
          • 8.3.3. Rest of Europe
            • 8.3.3.1. Market estimates & forecasts, 2016-2026 (USD Million)
            • 8.3.3.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 8.3.3.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 8.3.3.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
        • 8.4. Asia Drug Discovery Informatics Market Snapshot
          • 8.4.1. China
            • 8.4.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
            • 8.4.1.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 8.4.1.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 8.4.1.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
          • 8.4.2. India
            • 8.4.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
            • 8.4.2.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 8.4.2.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 8.4.2.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
          • 8.4.3. Japan
            • 8.4.3.1. Market estimates & forecasts, 2016-2026 (USD Million)
            • 8.4.3.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 8.4.3.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 8.4.3.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
          • 8.4.4. Rest of Asia Pacific
            • 8.4.4.1. Market estimates & forecasts, 2016-2026 (USD Million)
            • 8.4.4.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 8.4.4.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 8.4.4.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
        • 8.5. Latin America Drug Discovery Informatics Market Snapshot
          • 8.5.1. Brazil
            • 8.5.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
            • 8.5.1.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 8.5.1.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 8.5.1.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
          • 8.5.2. Mexico
            • 8.5.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
            • 8.5.2.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 8.5.2.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 8.5.2.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
        • 8.6. Rest of The World
          • 8.6.1. South America
            • 8.6.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
            • 8.6.1.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 8.6.1.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 8.6.1.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
          • 8.6.2. Middle East and Africa
            • 8.6.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
            • 8.6.2.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 8.6.2.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 8.6.2.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)

          Chapter 9. Competitive Intelligence

          • 9.1. Company Market Share (Subject to Data Availability)
          • 9.2. Top Market Strategies
          • 9.3. Company Profiles
            • 9.3.1. Jubilant Life Sciences
              • 9.3.1.1. Overview
              • 9.3.1.2. Financial (Subject to Data Availability)
              • 9.3.1.3. Product Summary
              • 9.3.1.4. Recent Developments
            • 9.3.2. IBM
            • 9.3.3. Infosys
            • 9.3.4. Thermo Fisher Scientific
            • 9.3.5. Perkinelmer
            • 9.3.6. Schrödinger
            • 9.3.7. Dassault Systèmes
            • 9.3.8. Charles River Laboratories
            • 9.3.9. Selvita
            • 9.3.10. GVK Biosciences

          Chapter 10. Research Process

          • 10.1. Research Process
            • 10.1.1. Data Mining
            • 10.1.2. Analysis
            • 10.1.3. Market Estimation
            • 10.1.4. Validation
            • 10.1.5. Publishing

Global Drug Discovery Informatics Market is valued approximately USD 1.89 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 11.20% over the forecast period 2019-2026. Drug discovery informatics is a functional process performed by biotechnology and pharmaceutical companies that requires the generation of very large data and information. Through application of modern engineering and computational approaches the models are analyzed, visualized and simulated for pharmacological profiling. Further, rising R&D expenditure on pharmaceuticals along with the increasing government focus on drug discovery are some key forces, driving the growth of the drug discovery informatics market over the forecast period of 2019-2026. For instance: According to the U.K. government in 2016, drug development sector and continuous manufacturing would receive funds around USD 82.5 million from government and private sources as part of its new USD 188 million effort and ‘Industry Strategy’ to establish six key research hubs in UK to boost research and development activities related to drug discovery. As a result, the adoption of the drug discovery informatics would increase thereby, contributing towards the growth of the market. However, high pricing and set up cost of informatics software impede the growth of the global drug discover informatics market.

The regional analysis of global drug discovery informatics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to well-established healthcare infrastructure along with the presence of various biotechnology and drug companies. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026 due to availability of low cost of human resources and manufacturing and availability of many qualified researchers. Also, the growth of the Asia-Pacific region is attributed owing to the ongoing drug development activities undertaken by government.

Major market player included in this report are:
Jubilant Life Sciences
IBM
Infosys
Thermo Fisher Scientific
Perkinelmer
Schrödinger
Dassault Systèmes
Charles River Laboratories
GVK Biosciences
Boehringer Ingelheim GmbH

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Function:

Sequencing & Target Data Analysis
Docking
Molecular Modelling
Libraries & Database Preparation
Other Functions

By Solution:

Software
Services

By End-User:

Pharmaceutical and Biotechnology Companies
Contract Research Organizations (CROS)
Others End Users

By Regions:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Drug Discovery Informatics Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


Summary:
Get latest Market Research Reports on Drug Discovery Informatics. Industry analysis & Market Report on Drug Discovery Informatics is a syndicated market report, published as Global Drug Discovery Informatics Market Size study, By Function (Sequencing & Target Data Analysis, Docking, Molecular Modelling, Libraries & Database Preparation and other functions), By Solutions (Software and Services), By End-users (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROS) and other end-users) and Regional Forecasts 2019-2026. It is complete Research Study and Industry Analysis of Drug Discovery Informatics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,950.00
$5,550.00
3,177.64
4,464.79
3,518.78
4,944.11
427,184.60
600,221.40
271,632.42
381,660.74
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report